| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.097 | 0.09 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |